Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Reilly

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Mental Health Nursing|October 27, 2006
Challenging the smoking culture within a mental health service supportivelyPaul Reilly, Leeann Murphy, Deirdre Alderton
Health and Technology|March 22, 2021
Assessing the potential use of blockchain technology to improve the sharing of public health data in a western Canadian provinceSarah Murphy, Paul Reilly, Teresa Murphy
British Journal of Clinical Pharmacology|September 6, 2012
Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjectsSebastian Härtter, Regina Sennewald, Gerhard Nehmiz, et al.
Clinical Pharmacokinetics|December 29, 2016
Authors' Reply to Kamel et al.: "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study"Stephan Glund, Paul Reilly, Joanne van Ryn, et al.
School Mental Health|November 23, 2018
Whose Responsibility is Adolescent's Mental Health in the UK? Perspectives of Key StakeholdersMichelle O'Reilly, Sarah Adams, Natasha Whiteman, et al.
Health Promotion International|July 31, 2018
Potential of social media in promoting mental health in adolescentsMichelle O'Reilly, Nisha Dogra, Jason Hughes, et al.
Clinical Drug Investigation|March 23, 2013
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjectsArne Ring, Karin Rathgen, Joachim Stangier, et al.
Clinical Child Psychology and Psychiatry|May 22, 2018
Is social media bad for mental health and wellbeing? Exploring the perspectives of adolescentsMichelle O'Reilly, Nisha Dogra, Natasha Whiteman, et al.
Journal of Thrombosis and Haemostasis : JTH|May 4, 2019
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatranStephan Glund, Kelly Coble, Dietmar Gansser, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 15, 2018
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran EliminationStephan Glund, Guanfa Gan, Viktoria Moschetti, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Mental Health Nursing|October 27, 2006
Challenging the smoking culture within a mental health service supportivelyPaul Reilly, Leeann Murphy, Deirdre Alderton
Health and Technology|March 22, 2021
Assessing the potential use of blockchain technology to improve the sharing of public health data in a western Canadian provinceSarah Murphy, Paul Reilly, Teresa Murphy
British Journal of Clinical Pharmacology|September 6, 2012
Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjectsSebastian Härtter, Regina Sennewald, Gerhard Nehmiz, et al.
Clinical Pharmacokinetics|December 29, 2016
Authors' Reply to Kamel et al.: "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study"Stephan Glund, Paul Reilly, Joanne van Ryn, et al.
School Mental Health|November 23, 2018
Whose Responsibility is Adolescent's Mental Health in the UK? Perspectives of Key StakeholdersMichelle O'Reilly, Sarah Adams, Natasha Whiteman, et al.
Health Promotion International|July 31, 2018
Potential of social media in promoting mental health in adolescentsMichelle O'Reilly, Nisha Dogra, Jason Hughes, et al.
Clinical Drug Investigation|March 23, 2013
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjectsArne Ring, Karin Rathgen, Joachim Stangier, et al.
Clinical Child Psychology and Psychiatry|May 22, 2018
Is social media bad for mental health and wellbeing? Exploring the perspectives of adolescentsMichelle O'Reilly, Nisha Dogra, Natasha Whiteman, et al.
Journal of Thrombosis and Haemostasis : JTH|May 4, 2019
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatranStephan Glund, Kelly Coble, Dietmar Gansser, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 15, 2018
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran EliminationStephan Glund, Guanfa Gan, Viktoria Moschetti, et al.
Pageof 5